Bioreactors Market Size
| Study Period | 2021 - 2029 |
| Market Size (2024) | USD 5.31 Billion |
| Market Size (2029) | USD 7.60 Billion |
| CAGR (2024 - 2029) | 7.45 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Bioreactors Market Analysis
The Bioreactor Market size is estimated at USD 5.31 billion in 2024, and is expected to reach USD 7.60 billion by 2029, growing at a CAGR of 7.45% during the forecast period (2024-2029).
Bioreactors in the pharmaceutical industry have great potential uses in the development of vaccines and other pharmaceutical products that are being used to mitigate the spread of COVID-19 across the world. The high demand from governmental vaccination programs and private entities to vaccinate large sections of the population requires scientists to work under pressure to shorten the time-to-market of developed vaccines. This has created a huge demand in the Bioreactor industry from the biopharmaceutical and biotechnology sectors during the early phase of the pandemic. According to an article published by Frontiers in August 2022, Cell culture bioreactors were widely used in viral vaccine production during the COVID-19 pandemic, and the development and application of bioreactors provided more efficient and cost-effective vaccine production to meet the global vaccine demand. Thus, COVID-19 had a positive impact on the Global bioreactors market initially. However, currently, the market growth slowed down as the pandemic subsided, and it is expected to witness stable growth during the forecast period of the study.
Factors such as the growth of bioreactors in pharmaceuticals, technological advancements, and adoption of single-use bioreactors (SUBs) and hybrid bioreactors are the prime drivers of the Bioreactors market currently.
Biopharmaceuticals are utilized in a range of applications, from being in the production of biopharmaceuticals to applications in tissue engineering, such as cell expansion and generation of 3D tissue constructs. Bioreactors in the pharmaceutical industry are used to provide a controllable environment, in terms of pH, temperature, nutrient supply, and shear stress for any cells or cellular constructs incorporated into them. For instance, according to an article published by PubMed Central in February 2022, bioreactors allow production to be increased to industrial scales, which can quickly and cheaply produce large amounts of secondary metabolites and recombinant proteins in a short time. Bioreactors have been utilized in many different areas of industry and research, including Microbial fermentation and the progression of in vitro models of 2D cultures and suspensions to 3D constructs, mimicking the natural physiological state in situ. They have also proven to be crucial medicines that are used in autoimmune disorders, cancer, asthma, and organ rejection. Thus, the growth of bioreactors, including those in the Medical bioreactor market, is a major factor augmenting the growth of the market.
Furthermore, technological advancements in bioreactors and fermenters have improved the flexibility, quality, and scalability of operations with low capital and energy requirements. These innovations in Upstream bioprocessing methods and analytical tools are projected to enhance process robustness, accelerate scale-up to industrial production, and drive the efficient use of resources. The extensive use of hybrid bioreactor technology in effective waste management has also further accelerated the expansion of the market.
Initiatives by major Bioreactor manufacturers are also boosting the market growth. For instance, in May 2021, Beckman Coulter Life Sciences launched its next-generation Biolector XT Microbioreactor in Germany. The BioLector XT Microbioreactor allows cultivation parameter monitoring, high-throughput strain screenings, and feeding strategy optimization.
Thus, owing to the benefits offered by bioreactor technology and its increasing applications, the Bioreactors market is expected to witness significant growth over the forecast period. However, concerns regarding the use of single-use bioreactors and limited storage capacity can hamper the market growth.
Bioreactors Market Trends
The Single-use Bioreactors Segment is Expected to Have A High Growth Rate During the Forecast Period
- Single-use bioreactors (SUBs), also known as Disposable bioreactors, from the material type segmentation are expected to have a high growth rate during the forecast period of the study. Recently, single-use bioreactors have been increasingly adopted in modern biopharmaceutical processes. This is primarily due to their unique ability to enhance flexibility, reduce investment, and limit operational costs.
- Owing to the high adoption rate and the increasing preference for deploying SUBs, market players, including major Bioreactor manufacturers, are continuously focusing on product launches and innovations. For instance, in February 2021, WuXi Biologics's MFG5 Drug Substance (DS) manufacturing facility in China successfully launched a GMP operation with a capacity of 36,000L, deploying nine 4,000L single-use bioreactors. As a major landmark in the company's global capacity planning, the GMP launch of MFG5 brings WuXi Biologics' current capacity to 90,000L, greatly enhancing the capability to enable global partners.
- Also, in June 2022, ABEC announced that mAbxience will equip their state-of-the-art cGMP facility in León, Spain with an additional ABEC 4,000L single-use custom single-run (CSR) bioreactor. This development positively impacts the Spain small scale bioreactors market outlook. Therefore, due to the above-mentioned factors, the segment is expected to witness growth.
North America Holds a Significant Market Share Currently, which is Expected to Continue Over the Forecast Period
- North America currently holds a significant share of the Global bioreactors market, and it is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the rise in collaboration among the industry and academic institutions. The United States holds the majority of the market in the North American region. The U.S. bioreactors market is expanding because pharmaceuticals and hi-tech product makers have announced multimillion-dollar investments to expand manufacturing capabilities.
- Additionally, the United States and Canada spend significantly on research and development expenses. For instance, according to the data published by NIH in May 2022, the United States spent around USD 7,847 million in biotechnology research in 2021, and it is expected to reach USD 8,142 million in 2022. The high amount being spent is expected to boost market growth since it translates to greater demand for new drugs and pharmaceutical ingredients that are manufactured by bioreactors.
- Various strategies, such as research and development, mergers and acquisitions, and product launches, are being adopted by domestic Bioreactor companies to strengthen their market position. For instance, in March 2021, Thermo Fisher Scientific launched its HyPerforma DynaDrive 3,000 L and HyPerforma DynaDrive 5,000 L single-use bioreactors due to strong demand for large-scale single-use systems. Product launches, such as these, are expected to boost the market growth during the forecast period.
- Also, the growing demand for biopharmaceutical products in the region and the focus on increasing localized production are expected to have a positive impact on the Pharmaceutical bioreactors market over the forecast period.
Bioreactors Industry Overview
The Bioreactor market is moderately fragmented and consists of several major players. In terms of market share, a few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new products at lower prices. Companies like Sartorius AG, Thermo Fisher Scientific Inc., Pall Corporation (Danaher Corporation), and Eppendorf AG, leading Bioreactor manufacturers and Bioreactor brands, hold a significant market share in the Bioreactors market.
Bioreactors Market Leaders
-
GE Healthcare
-
Merck KGaA
-
Eppendorf AG
-
Sartorius AG
-
Thermo Fisher Scientific Inc.
*Disclaimer: Major Players sorted in no particular order
Bioreactors Market News
- October 2022: Getinge AB announced that their bioreactors will support the Dutch government's initiative to produce animal products such as meat and milk proteins directly from animal and microbial cells.
- May 2022: Pall Corporation announced that its ICELL is a nano bioreactor that helped the Institute of Biomedicine of Seville (IBIS) to develop viral vectors for CAR-T therapy.
Bioreactors Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growth of Bioreactors in Pharmaceuticals
4.2.2 Technological Advancements in Bioreactors
4.2.3 Adoption of Single-use bioreactors (SUBs) and Hybrid Bioreactors
4.3 Market Restraints
4.3.1 Concerns Regarding the Use of Single-use Bioreactors (SUBs)
4.3.2 Limited Storage Capacity
4.4 Industry Attractiveness - Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type
5.1.1 Glass
5.1.2 Stainless Steel
5.1.3 Single-use
5.2 By Usage
5.2.1 Lab-scale Production
5.2.2 Pilot-scale Production
5.2.3 Full-scale Production
5.3 By Scale
5.3.1 5L-20L
5.3.2 20L-200L
5.3.3 200L-1,500L
5.3.4 Above 1,500L
5.4 By Control Type
5.4.1 Manual
5.4.2 Automated (MFCs)
5.5 By Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 GE Healthcare
6.1.2 Merck KGaA
6.1.3 Eppendorf AG
6.1.4 Sartorius AG
6.1.5 Pall Corporation (Danaher Corporation)
6.1.6 Getinge AB
6.1.7 Bioengineering AG
6.1.8 Infors HT
6.1.9 Solida Biotech GmBH
6.1.10 Solaris Biotech
6.1.11 Thermo Fisher Scientific Inc.
6.1.12 Esco Lifesciences Group Ltd
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Bioreactors Industry Segmentation
As per the scope of the report, bioreactors are large vessels used in industries that provide optimum conditions for the growth of microorganisms to carry out the biochemical process. They are used to speed up biochemical processes, such as fermentation and antibiotic drug production, where bacteria or yeast are added as inoculum to carry out the reaction. The bioreactor market is segmented by type (glass, stainless steel, and single-use), usage (lab-scale production, pilot-scale production, and full-scale production), scale (5L-20L, 20L-200L, 200L-1,500L, and above 1,500L), control (manual and automated), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments. The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally.
| By Type | |
| Glass | |
| Stainless Steel | |
| Single-use |
| By Usage | |
| Lab-scale Production | |
| Pilot-scale Production | |
| Full-scale Production |
| By Scale | |
| 5L-20L | |
| 20L-200L | |
| 200L-1,500L | |
| Above 1,500L |
| By Control Type | |
| Manual | |
| Automated (MFCs) |
| By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Bioreactors Market Research FAQs
How big is the Bioreactor Market?
The Bioreactor Market size is expected to reach USD 5.31 billion in 2024 and grow at a CAGR of 7.45% to reach USD 7.60 billion by 2029.
What is the current Bioreactor Market size?
In 2024, the Bioreactor Market size is expected to reach USD 5.31 billion.
Who are the key players in Bioreactor Market?
GE Healthcare, Merck KGaA, Eppendorf AG, Sartorius AG and Thermo Fisher Scientific Inc. are the major companies operating in the Bioreactor Market.
Which is the fastest growing region in Bioreactor Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Bioreactor Market?
In 2024, the North America accounts for the largest market share in Bioreactor Market.
What years does this Bioreactor Market cover, and what was the market size in 2023?
In 2023, the Bioreactor Market size was estimated at USD 4.91 billion. The report covers the Bioreactor Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Bioreactor Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
What are the major factors driving the Bioreactors Market?
The major factors driving the Bioreactors Market are a) Increasing demand for bioreactors in drug discovery, vaccine production, and biomanufacturing processes b) Increasing demand for biodegradable products
Bioreactors Industry Report
The global bioreactors market is experiencing substantial growth, driven by increasing demands for vaccines, monoclonal antibodies, and efficient drug development processes. Innovations like single-use bioreactors and advanced control systems are boosting production capabilities in the pharmaceutical and biotechnology sectors. This growth is supported by significant R&D investments and government initiatives to improve healthcare solutions.
The market size is expanding, with North America leading this expansion, supporting both pilot-scale and full-scale production needs. The prevalence of chronic diseases emphasizes the need for quick diagnostics and therapies. The shift towards single-use bioreactors, reducing cross-contamination and operational costs, signifies a move towards more flexible and sustainable manufacturing processes.
The industry growth is underscored by the vital role of bioreactors in advancing healthcare and pharmaceuticals. The industry analysis highlights the importance of market trends and market forecast in understanding the future landscape. The industry research provides insights into market leaders and market value, while the industry outlook and market overview offer a comprehensive perspective on current developments.
The global market is segmented by type, usage, scale, control, and geography, with the market report offering detailed market segmentation and market review. The market growth is driven by innovations and increased demand, as detailed in the industry reports. The market predictions and market data emphasize the importance of staying informed about industry statistics and industry trends.
For a detailed analysis, the report example and report pdf provide in-depth information, making it a valuable resource for research companies. This evolving market underscores the importance of industry information and industry sales in shaping the future of bioreactors in the pharmaceutical industry.
Bioreactors Market Report Snapshots
